Search for Primary Infection by Pneumocystis carinii in a Cohort of Normal, Healthy Infants
Author
dc.contributor.author
Vargas Munita, Sergio
Author
dc.contributor.author
Hughes, Walter T.
Author
dc.contributor.author
Santolaya de Pablo, María Elena
Author
dc.contributor.author
Ulloa, Ana V.
Author
dc.contributor.author
Ponce, Carolina A.
Author
dc.contributor.author
Cabrera, Cecilia E.
Author
dc.contributor.author
Cumsille, Francisco
Author
dc.contributor.author
Gigliotti, Francis
Admission date
dc.date.accessioned
2018-06-13T15:44:09Z
Available date
dc.date.available
2018-06-13T15:44:09Z
Publication date
dc.date.issued
2001
Cita de ítem
dc.identifier.citation
Clinical Infectious Diseases 2001; 32:855–61
es_ES
Identifier
dc.identifier.other
10.1086/319340
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/148834
Abstract
dc.description.abstract
To determine whether Pneumocystis carinii is associated with clinical illness in the competent host, 107 normal, healthy infants were enrolled in a 2-year prospective cohort study in Chile. P. carinii was identified by specific stains and nested-deoxyribonucleic acid (DNA) amplification of the large subunit mitochondrial ribosomal ribonucleic acid gene of P. carinii f. sp. hominis, and seroconversion was assessed by enzyme-linked immunosorbent assay of serum samples drawn every 2 months. P. carinii DNA was identified in nasopharyngeal aspirates obtained during episodes of mild respiratory infection in 24 (32%) of 74 infants from whom specimens were available for testing. Three (12.5%) of those 24 infants versus 0 of 50 infants who tested negative for P. carinii had apnea episodes. Seroconversion developed in 67 (85%) of 79 infants who remained in the study by 20 months of age and occurred in the absence of any symptoms of disease in 14 (20.8%). The study indicates that P. carinii DNA can be frequently detected in healthy infants, and it raises the hypothesis that they may be an infectious reservoir of P. carinii in the community. Further investigation is needed to identify whether P. carinii causes overt respiratory disease in infants.
es_ES
Patrocinador
dc.description.sponsorship
This work was supported in part by Fondo Nacional de
Desarrollo Científico y Tecnolo´gico (FONDECYT research grant 1960940), Santiago,
Chile; the St. Jude International Outreach Program and American-Lebanese-
Syrian–Associated Charities, St. Jude Children’s Research Hospital, Memphis; and
the National Institutes of Health (grant AI-23302).